Javascript must be enabled to continue!
S-AMLODIPINE AS A MODERN EFFECTIVE ANTIHYPERTENSIVE AND AN ANTIANGINAL AGENT
View through CrossRef
The aim: Study of the clinical and hemodynamic effects of S-amlodipine in patients with arterial hypertension associated with coronary artery disease, in individuals with preserved LV systolic function.
Materials and methods: The study includes 51 patients with arterial hypertension associated with coronary artery disease, who were treated with S-amlodipine.
Results: This study shows the high clinical effectiveness of the use of S-amlodipine in patients with arterial hypertension associated with coronary artery disease. We reveal that treatment of hypertensive patients with coronary artery disease with S-amlodipine leads to improvement of LV diastolic dysfunction, bringing it closer to normal values.
Conclusions: Clinical effectiveness was associated with positive changes in hemodynamics, and was expressed in the normalization of the left ventricle diastolic function parameters, about which indirectly indicates decreasing of end-diastolic pressure.
Title: S-AMLODIPINE AS A MODERN EFFECTIVE ANTIHYPERTENSIVE AND AN ANTIANGINAL AGENT
Description:
The aim: Study of the clinical and hemodynamic effects of S-amlodipine in patients with arterial hypertension associated with coronary artery disease, in individuals with preserved LV systolic function.
Materials and methods: The study includes 51 patients with arterial hypertension associated with coronary artery disease, who were treated with S-amlodipine.
Results: This study shows the high clinical effectiveness of the use of S-amlodipine in patients with arterial hypertension associated with coronary artery disease.
We reveal that treatment of hypertensive patients with coronary artery disease with S-amlodipine leads to improvement of LV diastolic dysfunction, bringing it closer to normal values.
Conclusions: Clinical effectiveness was associated with positive changes in hemodynamics, and was expressed in the normalization of the left ventricle diastolic function parameters, about which indirectly indicates decreasing of end-diastolic pressure.
Related Results
Pharmacogenomics and the Concept of Personalized Medicine for the Management of Hypertension
Pharmacogenomics and the Concept of Personalized Medicine for the Management of Hypertension
Hypertension poses a significant global burden due to low adherence to antihypertensive medications. Hypertension treatment aims to bring blood pressure within physiological ranges...
ASSA13-16-4 The Influence of Combination of Amlodipine and Valsartan on Plasma Free Fat Acid and Adiponectin in Patients with Essential Hypertension
ASSA13-16-4 The Influence of Combination of Amlodipine and Valsartan on Plasma Free Fat Acid and Adiponectin in Patients with Essential Hypertension
Objective
To investigate the influence of combination therapy of amlodipine and valsartanon on the plasma adiponectin (ADPN) and free fatty acids (FFAs) levels in...
Anti-ischemic therapy and stress testing: pathophysiologic, diagnostic and prognostic implications
Anti-ischemic therapy and stress testing: pathophysiologic, diagnostic and prognostic implications
AbstractAnti-ischemic therapy, in particular beta-blockers, is the most commonly employed drug for the control of myocardial ischemia in patients with stable coronary artery diseas...
Pharmacokinetic interactions of esaxerenone with amlodipine and digoxin in healthy Japanese subjects
Pharmacokinetic interactions of esaxerenone with amlodipine and digoxin in healthy Japanese subjects
Abstract
Background
To investigate the effects of coadministration of esaxerenone with amlodipine on the pharmacokinetics (PK) of each drug, and of esaxerenone on the PK of digoxin...
GW24-e2417 Insulin-like growth factor-I and brachial-ankle pulse wave velocity in patients with essential hypertension
GW24-e2417 Insulin-like growth factor-I and brachial-ankle pulse wave velocity in patients with essential hypertension
Objectives
To investigate the relationship between serum insulin-like growth factor-1 (IGF-1) and brachial-ankle pulse wave velocity (baPWV) in patients with esse...
GW24-e1158 Aliskiren/amlodipine versus aliskiren/hydrochlorothiazide in hypertension: Indirect-comparison meta-analysis of randomised controlled trials
GW24-e1158 Aliskiren/amlodipine versus aliskiren/hydrochlorothiazide in hypertension: Indirect-comparison meta-analysis of randomised controlled trials
Objectives
Aliskiren, a direct renin inhibitor, is effective for reducing blood pressure (BP) in patients with hypertension when combined with a calcium channel b...
EFFECT OF DIFFERENT ANTIHYPERTENSIVE STRATEGIES ON THE MICROALBUMINURIA EXCRETION
EFFECT OF DIFFERENT ANTIHYPERTENSIVE STRATEGIES ON THE MICROALBUMINURIA EXCRETION
Objectives
Giving different therapy to hypertensive patients with microalbuminuria in order to find the appropriate individual therapy for this kind of high-risk ...
A Comparative Pharmaceutical Evaluation of Amlodipine (5mg)
A Comparative Pharmaceutical Evaluation of Amlodipine (5mg)
The objective of this study is to evaluate the pharmaceutical properties of three brands of Amlodipine (5mg) for local and international pharmaceutical companies. The main aim is t...

